Researchers continue to excited about the medication , a novel dual treatment showing significant results in early trials for size management. It functions by targeting both hormones : GLP-1 and GIP, that , when activated , assist control hunger and boost calorie burn. Early observations demonstrate considerable size loss and likely benefits for in